Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.

Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.

REVUE NEUROLOGIQUE, published by MASSON EDITEUR, is a prestigious academic journal that plays an essential role in the field of neurology. With a rich history spanning from 1946 to the present, this journal focuses on both foundational and clinical aspects of neurology, underscoring its significance within the medical community. Holding an impressive Q2 ranking in both general and clinical neurology categories as of 2023, REVUE NEUROLOGIQUE is recognized for its contribution to advancing neurological science, as evidenced by its Scopus rankings, with a notable position in the 62nd percentile for clinical neurology. The journal fosters an environment for rigorous research and is instrumental for professionals and scholars aiming to stay abreast of the latest developments in neurological disorders and treatments. Although it is not an open-access publication, it offers a wealth of vital research through its issues, appealing to those engaged in both clinical practice and academic research in neurology.

Indian Journal of Paediatric Dermatology (ISSN: 2319-7250; E-ISSN: 2319-7269), published by Wolters Kluwer Medknow Publications, stands as a pivotal resource in the specialized field of paediatric dermatology. As a peer-reviewed open access journal since 2013, it aims to disseminate cutting-edge research, clinical practices, and innovative developments that cater to the specific dermatological needs of children. The journal provides an essential forum for collaboration among researchers, clinicians, and students, facilitating the sharing of knowledge on a wide array of topics, including skin conditions unique to paediatric populations, treatment methodologies, and advancements in dermatological care. With a commitment to enhancing the understanding and treatment of paediatric skin diseases, this journal plays a critical role in shaping best practices and informing future research directions in a rapidly evolving field.

Neurohospitalist is a premier journal dedicated to advancing the field of clinical neurology, published by SAGE Publications Ltd. With an ISSN of 1941-8744 and an E-ISSN of 1941-8752, this journal caters to the growing demand for high-quality research and discussions around neurological emergencies and hospital-based care. Established in 2011 and slated to continue through 2024, Neurohospitalist aims to foster comprehensive and impactful studies that contribute to clinical practice and patient outcomes in neurology. It holds a respectable Q3 categorization in Neurology (clinical) for 2023, indicating its valuable contributions amidst a competitive landscape. Although it does not offer open access options, researchers and professionals can access essential findings that push the boundaries of contemporary neurology. By bringing together innovative research, expert reviews, and case studies, Neurohospitalist serves as a vital resource for those engaged in the dynamics of neurological care, encouraging the exchange of knowledge among clinicians, researchers, and students alike.

EPILEPSIA is a premier academic journal published by Wiley, with a storied history dating back to 1909, making it a cornerstone in the field of epilepsy research and neurology. With an impressive impact factor reflecting its robust contribution to the academic community, EPILEPSIA is categorized in the top quartile (Q1) in both neurology and clinical neurology as of 2023, underscoring its significance and prestige. The journal is ranked #15 out of 192 in Neuroscience & Neurology and #34 out of 400 in Medicine & Neurology (clinical) within Scopus, indicating its essential role in advancing knowledge and treatments related to epilepsy. Researchers and clinicians are encouraged to contribute groundbreaking studies, case reports, and reviews that inform best practices and improve patient outcomes. Although EPILEPSIA currently does not offer open access options, its detailed exploration of both fundamental and clinical aspects of epilepsy ensures wide dissemination of crucial findings among professionals and students alike, furthering the understanding and management of this complex condition.

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

CHILDS NERVOUS SYSTEM is a distinguished academic journal published by SPRINGER, focusing on the vital intersections of pediatrics, neurology, and child health. With an ISSN of 0256-7040 and an E-ISSN of 1433-0350, this journal has been an important platform for research since its inception in 1985 and continues to contribute significantly to the field, as reflected in its impressive quartile standings: Q3 in Medicine (miscellaneous) and Neurology (clinical), and Q2 in Pediatrics, Perinatology, and Child Health for 2023. Despite its Q3 rankings in two categories, it holds a respectable position in Scopus rankings, showcasing its relevance among peers in pediatric and neurological studies. The journal aims to disseminate new research and insights that enhance the understanding of neurological conditions in children, offering a comprehensive view of both clinical practices and advancements in medicine. Though it currently does not provide Open Access options, its rigorous peer-review process ensures high-quality content that is indispensable for researchers, clinicians, and professionals dedicated to improving child health outcomes.

Neurology and Therapy, published by SPRINGER LONDON LTD, stands as a pivotal platform for researchers and practitioners in the field of neurology and its therapeutic applications. This Open Access journal, active since 2012, facilitates the dissemination of innovative studies and cutting-edge findings aimed at improving neurological health. With an impressive ranking in the 2023 Scopus Rankings, where it holds a Q2 category in Neurology and a Q1 category in Clinical Neurology, it underscores its prominence in advancing neurological research. The journal's intriguing scope encompasses a wide-ranging exploration of neurological disorders, treatment methodologies, and healthcare strategies, making it a valuable resource for those vested in enhancing patient outcomes. With an appealing average impact factor, readers are encouraged to dive into the latest advancements and engage with the scholarly discussions that are shaping the future of neurology.